Guido Ferrari
Professor in Surgery
Research Professor in Molecular Genetics and Microbiology
Affiliate, Duke Global Health Institute
Guido Ferrari
Professor in Surgery
Research Professor in Molecular Genetics and Microbiology
Affiliate, Duke Global Health Institute
Dr. Ferrari is currently aProfessor in the Department of Surgery, Division of Surgical Sciences at Duke University Medical Center. He is directing the CFAR Immunology Core and ADCC laboratories for the HVTN, CAVD, and PAVEG central laboratory at Duke. He served as a WHO/UNAIDS Vaccine Initiative consultant for six years, and coordinated the organization of 5 international workshops for the transfer of ELISpot and ICS technologies to new laboratory sites involved in HIV vaccine studies. He is involved in several initiative supported by NIH and IAS to mentor young investigators in limited resources countries to fight infectious diseases that include AIDS, tuberculosis, and malaria.
Projects
Publications
-
Hargarten PM, Porth CG, Berrong M, Weed D, Carper M, Denny TN, et al. Decreased variability in the site-specific results during participation in the External Quality Assurance Program Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay. J Immunol Methods. 2024 Oct 23;534:113770.Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, et al. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. EBioMedicine. 2024 Oct;108:105320.Nelson AN, Shen X, Vekatayogi S, Zhang S, Ozorowski G, Dennis M, et al. Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques. Sci Immunol. 2024 Aug 30;9(98):eadm7097.Huang Y, Alam S, Andersen-Nissen E, Carpp LN, Dintwe OB, Flach BS, et al. Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses. Viruses. 2024 Aug 27;16(9).
See more publications at Scholars@Duke